JENNIFER DESMOND: Open Payments
NPI 1366963795 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 11 payments from 7 companies in 2025. Trend: 2023 $647 · 2024 $483 · 2025 $656
Food & beverage: $596Consulting: $60
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 4 | $187 |
| Janssen Biotech, Inc. | 1 | $130 |
| Amgen Inc. | 1 | $105 |
| Biogen, Inc. | 2 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $74 |
| Octapharma USA, Inc. | 1 | $56 |
| Lundbeck LLC | 1 | $15 |
Products named: Leqembi, KRYSTEXXA, HYQVIA, TYSABRI, PANZYGA, VUMERITY, VYEPTI.
Industry payments across TX — which companies pay providers there.
